Adnexus Therapeutics News
Most Popular Adnexus Therapeutics Story
BMS pays $505M for Adnexus
Adnexus Therapeutics is abandoning its move to go public, opting for a buyout by Bristol-Myers Squibb that will net $430 Read more...
Latest Headlines
- September 24, 2007
- August 22, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
